hnRNPA1 exhibits minimal expression in normal tissues, but it is highly expressed in various types of malignancies, including breast cancer, prostate cancer, oral cancer, neuroblastoma, bladder cancer, lung cancer, colon cancer, and hepatocellular cancer. Here, HNRNPA1 is linked to urinary bladder cancer.